5[1]Yoshida-S,Kurokohchi-K,Arima-K,et al.Clinical significance of lens culinaris agglutinin-reactive fraction of of serum alpha-fetopro-tein in patients with hepatoedlular carcinoma[J].Int J Oneol,2002,20(2):305～309.
6[4]Takeda S,Nakao A.Genetic detection and clinical application in patients with hepatocellular carcinoma[J].Nippon Geka Gakkai Zasshi,2002,103(6):472～475.
7[5]PaVeiF,Lotzniker M,Scaralml liM,et al.Effi-ciency of composite laboratory test in the diag-nosis of liver malignancies[J].Int J Biol Makers,1989,14(3):163.
8[1O]Shigetoshi F,Motohiko T,Seishi M,et al.Tumor markers in early diaguosis,follow-up and management of patients with hepatocellular carcinoma[J].Oncol-ogy,2002,62(S1):57～63.
9[11]Shimizu A,Shiraki K,Ito et al.Sequential fluctuation pattern of serum desgamma-carboxy prothrombin levels detected by hish-sen-sitive eleetrochemiluminescenee system as an eystem as an early predictive marker for hepatocellular carcinoma in patients with cir-rhosis[J].Int Mol Med,2002,9(3):245～250.
10[12]Blohe GC,Sehiemann WP,Lodish HF.Role of transforming growth factor beta in human disease[J].N Engl J Med,2000,342(18):1350～1358.
